Influence of Gender on Glycemic Control and Hypoglycemia in T2DM Patients Initiating Insulin Glargine

被引：0
|
作者：
Kautzky-Willer, Alexandra
Traylor, Louise
Landgraf, Wolfgang
Charbonnel, Bernard
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1007-P
引用
收藏
页码：A257 / A257
页数：1
相关论文
共 50 条
  • [1] New Insulin Glargine 300 U/ml: Glycemic Control and Hypoglycemia in Insulin Naive People with T2DM (EDITION 3)
    Bolli, Geremia B.
    Riddle, Matthew C.
    Bergenstal, Richard M.
    Ziemen, Monika
    Sestakauskas, Kastytis
    Goyeau, Harmonie
    Home, Phillip D.
    DIABETES, 2014, 63 : A19 - A19
  • [2] AGE OF DIABETES ONSET: GLYCEMIC CONTROL AND HYPOGLYCEMIA BENEFIT WITH NEW INSULIN GLARGINE 300U/ML IN T2DM
    Twigg, S.
    Khunti, K.
    Forst, T.
    Janez, A.
    Merino-Trigo, A.
    Stella, P.
    Grisoni, M. L.
    Galstyan, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A45 - A45
  • [3] Age, BMI, and Diabetes Duration: Effect on Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes (T2DM)
    Twigg, Stephen M.
    Escalada, Javier
    Grisoni, Marie-Lise
    Stella, Peter
    Merino-Trigo, Ana
    Lavalle Gonzalez, Fernando J.
    Cariou, Bertrand
    Meneghini, Luigi F.
    DIABETES, 2015, 64 : A260 - A260
  • [4] Meta-analysis of Clinical Outcomes According to Age in T2DM Patients Initiating Insulin Glargine
    Haak, Thomas J.
    Traylor, Louise
    Landgraf, Wolfgang
    Owens, David R.
    DIABETES, 2015, 64 : A256 - A257
  • [5] NEW INSULIN GLARGINE 300 U/ML: GLYCEMIC CONTROL AND HYPOGLYCEMIA IN A META-ANALYSIS OF EDITION CLINICAL TRIALS IN PEOPLE WITH T2DM
    Ritzel, R. A.
    Roussel, R.
    Bolli, G. B.
    Vinet, L.
    Yki-Jarvinen, H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A16 - A17
  • [6] Optimizing Glycemic Control in T2DM Patients Previously Treated With Intensive Insulin Therapy and Switched to Exenatide-Insulin Glargine Combination
    Avramidis, Iakovos
    Spyridonidou, Christina
    Stoimenis, Dimitris
    Lalia, Antigoni
    DIABETES, 2013, 62 : A261 - A261
  • [7] Effects of Insulin Glargine vs Thiazolidinediones (TZDs) on Glycemic and Lipid Variables in T2DM
    Hollander, Priscilla
    Rosenberg, Noah
    Chaudhuri, Ajay
    Nesto, Richard W.
    Rosenstock, Julio
    Meneghini, Luigi F.
    Dandona, Paresh
    Riddle, Matthew C.
    DIABETES, 2009, 58 : A522 - A522
  • [8] Initiating Basal Insulin Supported Oral Therapy (BOT) with Insulin Glargine 300 U/mL (Gla-300) Improves Glycemic Control in Patients (Pts) with Type 2 Diabetes (T2DM) without Increasing Hypoglycemia Risk
    Pfohl, Martin
    Fritsche, Andreas
    Anderten, Helmut
    Pegelow, Katrin
    Pscherer, Stefan
    Seufert, Jochen
    DIABETES, 2018, 67
  • [9] Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
    Ting-Ting Yin
    Yan Bi
    Ping Li
    Shan-Mei Shen
    Xiao-Lu Xiong
    Li-Jun Gao
    Can Jiang
    Yan Wang
    Wen-Huan Feng
    Da-Long Zhu
    Diabetes Therapy, 2018, 9 : 1253 - 1267
  • [10] Effects of Metformin and Sulfonylurea on Efficacy and Hypoglycemia After Addition of Insulin Glargine or NPH in T2DM
    Bretzel, Reinhard
    Traylor, Louise
    Landgraf, Wolfgang
    DIABETES, 2014, 63 : A237 - A238
12345